menu search

VACC / Vaccitech to Present at the H.C. Wainwright Global Investment Conference

Vaccitech to Present at the H.C. Wainwright Global Investment Conference
OXFORD, United Kingdom, May 20, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced that the Company's Chief Executive Officer, Bill Enright, and Chief Financial Officer, Georgy Egorov, will present at the H.C. Wainwright Global Investment Conference at 12:00 p.m. EDT on Tuesday, May 24, 2022. The conference will be held both in person in Miami and virtually. Read More
Posted: May 20 2022, 11:30
Author Name: GlobeNewsWire
Views: 102615

VACC News  

Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B

By GlobeNewsWire
June 21, 2023

Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B

OXFORD, United Kingdom, June 21, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disc more_horizontal

Vaccitech to Present at the H.C. Wainwright Global Investment Conference

By GlobeNewsWire
May 20, 2022

Vaccitech to Present at the H.C. Wainwright Global Investment Conference

OXFORD, United Kingdom, May 20, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disco more_horizontal

Vaccitech: Aiming For A Cure In Chronic Hepatitis B

By Seeking Alpha
April 3, 2022

Vaccitech: Aiming For A Cure In Chronic Hepatitis B

Vaccitech: Aiming For A Cure In Chronic Hepatitis B more_horizontal


Search within

Pages Search Results: